$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer’s Disease 원문보기

PloS one, v.10 no.3, 2015년, pp.e0119452 -   

Graham, Stewart F. (Advanced Asset Technology Centre, Institute for Global Food Security, Queen’s University Belfast, Stranmillis Road, Belfast, BT9 5AG, United Kingdom) ,  Chevallier, Olivier P. (Advanced Asset Technology Centre, Institute for Global Food Security, Queen’s University Belfast, Stranmillis Road, Belfast, BT9 5AG, United Kingdom) ,  Elliott, Christopher T. (Advanced Asset Technology Centre, Institute for Global Food Security, Queen’s University Belfast, Stranmillis Road, Belfast, BT9 5AG, United Kingdom) ,  Hölscher, Christian (Division of Biomedical Sciences and Life Sciences, Lancaster University, Lancaster, LA1 4YG, United Kingdom) ,  Johnston, Janet (Ageing Group, Centre for Public Health, Queen's University Belfast, Belfast, BT12 6BA, United Kingdom) ,  McGuinness, Bernadette (Ageing Group, Centre for Public Health, Queen's University Belfast, Belfast, BT12 6BA, United Kingdom) ,  Kehoe, Patrick G. (Dementia Research Group, Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Frenchay Hospital, Bristol, BS16 1LE, United Kingdom) ,  Passmore, Anthony Peter (Ageing Group, Centre for Public Health, Queen's Univer) ,  Green, Brian D.

Abstract AI-Helper 아이콘AI-Helper

This study combined high resolution mass spectrometry (HRMS), advanced chemometrics and pathway enrichment analysis to analyse the blood metabolome of patients attending the memory clinic: cases of mild cognitive impairment (MCI; n = 16), cases of MCI who upon subsequent follow-up developed Alzheime...

참고문헌 (47)

  1. 1 Monge-Argiles JA , Munoz-Ruiz C , Pampliega-Perez A , Gomez-Lopez MJ , Sanchez-Paya J , Rodriguez Borja E , et al Biomarkers of Alzheimer's disease in the cerebrospinal fluid of spanish patients with mild cognitive impairment . Neurochem Res 2011 ; 36 : 986 – 93 . 10.1007/s11064-011-0438-x 21399907 

  2. 2 Knight WD , Okello AA , Ryan NS , Turkheimer FE , Rodriguez Martinez de Llano S , Edison P , et al Carbon-11-pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers . Brain 2011 ; 134 : 293 – 300 . 10.1093/brain/awq310 21084313 

  3. 3 Dubois B , Feldman HH , Jacova C , Dekosky ST , Barberger-Gateau P , Cummings J , et al Research criteria for the diagnosis of alzheimer's disease: Revising the NINCDS-ADRDA criteria . Lancet Neurol 2007 ; 6 : 734 – 46 . 17616482 

  4. 4 Petersen RC . Mild cognitive impairment as a diagnostic entity . J Intern Med 2004 ; 256 : 183 – 94 . 15324362 

  5. 5 Petersen RC , Smith GE , Waring SC , Ivnik RJ , Tangalos EG , Kokmen E . Mild cognitive impairment: Clinical characterization and outcome . Arch Neurol 1999 ; 56 : 303 – 8 . 10190820 

  6. 6 Lopez OL , Kuller LH , Becker JT , Dulberg C , Sweet RA , Gach HM , et al Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study . Arch Neurol 2007 ; 64 : 416 – 20 . 17353386 

  7. 7 Mitchell AJ , Shiri-Feshki M . Rate of progression of mild cognitive impairment to dementia—meta-analysis of 41 robust inception cohort studies . Acta Psychiatr Scand 2009 ; 119 : 252 – 65 . 10.1111/j.1600-0447.2008.01326.x 19236314 

  8. 8 Beckonert O , Keun HC , Ebbels TM , Bundy J , Holmes E , Lindon JC , et al Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts . Nat Protoc 2007 ; 2 : 2692 – 703 . 18007604 

  9. 9 Kaddurah-Daouk R , Zhu H , Sharma S , Bogdanov M , Rozen SG , Matson W , et al Alterations in metabolic pathways and networks in alzheimer's disease . Transl Psychiatry 2013 ; 3 : e244 10.1038/tp.2013.18 23571809 

  10. 10 Graham SF , Holscher C , McClean P , Elliott C , Green B . Brain tissue and plasma used to metabolically phenotype alzheimer’s disease in APP/PS1 mice . Metabolomics 2013 ; 9 : 974 – 983 . 

  11. 11 Ibanez C , Simo C , Barupal DK , Fiehn O , Kivipelto M , Cedazo-Minguez A , et al A new metabolomic workflow for early detection of alzheimer's disease . J Chromatogr A 2013 ; 1302 : 65 – 71 . 10.1016/j.chroma.2013.06.005 23827464 

  12. 12 Folstein MF , Folstein SE , McHugh PR . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician . J Psychiatr Res 1975 ; 12 : 189 – 98 . 1202204 

  13. 13 Mioshi E , Dawson K , Mitchell J , Arnold R , Hodges JR . The addenbrooke's cognitive examination revised (ACE-R): A brief cognitive test battery for dementia screening . Int J Geriatr Psychiatry 2006 ; 21 : 1078 – 85 . 16977673 

  14. 14 Winblad B , Palmer K , Kivipelto M , Jelic V , Fratiglioni L , Wahlund LO , et al Mild cognitive impairment—beyond controversies, towards a consensus: Report of the international working group on mild cognitive impairment . J Intern Med 2004 ; 256 : 240 – 6 . 15324367 

  15. 15 McKhann G , Drachman D , Folstein M , Katzman R , Price D , Stadlan EM . Clinical diagnosis of alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on alzheimer's disease . Neurology 1984 ; 34 : 939 – 44 . 6610841 

  16. 16 Brandt J , Aretouli E , Neijstrom E , Samek J , Manning K , Albert MS , et al Selectivity of executive function deficits in mild cognitive impairment . Neuropsychology 2009 ; 23 : 607 – 18 . 10.1037/a0015851 19702414 

  17. 17 Nordlund A , Rolstad S , Klang O , Edman A , Hansen S , Wallin A . Two-year outcome of MCI subtypes and aetiologies in the goteborg MCI study . J Neurol Neurosurg Psychiatry 2010 ; 81 : 541 – 6 . 10.1136/jnnp.2008.171066 19965857 

  18. 18 Summers MJ , Saunders NL . Neuropsychological measures predict decline to alzheimer's dementia from mild cognitive impairment . Neuropsychology 2012 ; 26 : 498 – 508 . 10.1037/a0028576 22612573 

  19. 19 Graham SF , Chevallier OP , Roberts D , Holscher C , Elliott CT , Green BD . An investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of alzheimer’s disease . Analytical Chemistry 2012 ; 85 : 1803 – 11 . 

  20. 20 Zhang A , Zhou X , Zhao H , Guan Y , Zhou S , et al ( 2014 ) Rapidly improved determination of metabolites from biological data sets using the high-efficient TransOmics tool . Mol Biosyst 10 : 2160 – 2165 . 10.1039/c4mb00222a 24889752 

  21. 21 Want EJ , Wilson ID , Gika H , Theodoridis G , Plumb RS , Shockcor J , et al Global metabolic profiling procedures for urine using UPLC-MS . Nat Protoc 2010 ; 5 : 1005 – 18 . 10.1038/nprot.2010.50 20448546 

  22. 22 Tsang TM , Haselden JN , Holmes E . Metabonomic characterization of the 3-nitropropionic acid rat model of huntington's disease . Neurochem Res 2009 ; 34 : 1261 – 71 . 10.1007/s11064-008-9904-5 19148750 

  23. 23 Oresic M , Hyotylainen T , Herukka S , Sysi-Aho M , Mattila I , Seppanan-Laakso T , et al Metabolome in progression to alzheimer’s disease . Translational Psych . 2011 , 1 : e57 

  24. 24 Trushina E , Dutta T , Persson XM , Mielke MM , Petersen RC . Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and alzheimer's disease using metabolomics . PLoS One 2013 ; 8 : e63644 10.1371/journal.pone.0063644 23700429 

  25. 25 Motsinger-Reif A , Zhu H , Kling M , Matson W , Sharma S , Fiehn O , et al Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating alzheimer's disease from normal cognitive aging . Acta Neuropathologica Communications 2013 ; 1 : 28 10.1186/2051-5960-1-28 24252434 

  26. 26 Vural H , Sirin B , Yilmaz N , Eren I , Delibas N . The role of arginine-nitric oxide pathway in patients with alzheimer disease . Biol Trace Elem Res 2009 ; 129 : 58 – 64 . 10.1007/s12011-008-8291-8 19099206 

  27. 27 Becker-Catania SG , Gregory TL , Yang Y , Gau CL , de Vellis J , Cederbaum SD , et al Loss of arginase I results in increased proliferation of neural stem cells . J Neurosci Res 2006 ; 84 : 735 – 46 . 16773651 

  28. 28 Maxwell AJ , Anderson B , Zapien MP , Cooke JP . Endothelial dysfunction in hypercholesterolemia is reversed by a nutritional product designed to enhance nitric oxide activity . Cardiovasc Drugs Ther 2000 ; 14 : 309 – 16 . 10935153 

  29. 29 Esch F , Lin KI , Hills A , Zaman K , Baraban JM , Chatterjee S , et al Purification of a multipotent antideath activity from bovine liver and its identification as arginase: Nitric oxide-independent inhibition of neuronal apoptosis . J Neurosci 1998 ; 18 : 4083 – 95 . 9592089 

  30. 30 Wallace HM , Fraser AV , Hughes A . A perspective of polyamine metabolism . Biochem J 2003 ; 376 : 1 – 14 . 13678416 

  31. 31 Inoue K , Tsutsui H , Akatsu H , Hashizume Y , Matsukawa N , Yamamoto T , et al Metabolic profiling of Alzheimer's disease brains . Sci Rep 2013 ; 3 : 2364 10.1038/srep02364 23917584 

  32. 32 Yatin SM , Varadarajan S , Link CD , Butterfield DA . In vitro and in vivo oxidative stress associated with alzheimer's amyloid beta-peptide (1–42) . Neurobiol Aging 1999 ; 20 : 325 , 30 ; discussion 339–42. 10588580 

  33. 33 Yatin SM , Yatin M , Varadarajan S , Ain KB , Butterfield DA . Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity . J Neurosci Res 2001 ; 63 : 395 – 401 . 11223914 

  34. 34 Makitie LT , Kanerva K , Polvikoski T , Paetau A , Andersson LC . Brain neurons express ornithine decarboxylase-activating antizyme inhibitor 2 with accumulation in alzheimer's disease . Brain Pathol 2010 ; 20 : 571 – 80 . 10.1111/j.1750-3639.2009.00334.x 19832840 

  35. 35 Rossor MN , Garrett NJ , Johnson AL , Mountjoy CQ , Roth M , Iversen LL . A post-mortem study of the cholinergic and GABA systems in senile dementia . Brain 1982 ; 105 : 313 – 30 . 7082992 

  36. 36 Salek RM , Xia J , Innes A , Sweatman BC , Adalbert R , Randle S , et al A metabolomic study of the CRND8 transgenic mouse model of alzheimer's disease . Neurochem Int 2010 ; 56 : 937 – 47 . 10.1016/j.neuint.2010.04.001 20398713 

  37. 37 Lalande J , Halley H , Balayssac S , Gilard V , Dejean S , Martino R , et al 1H NMR metabolomic signatures in five brain regions of the AbetaPPswe Tg2576 mouse model of alzheimer's disease at four ages . J Alzheimers Dis 2014 ; 39 : 121 – 43 . 10.3233/JAD-130023 24145382 

  38. 38 Lowe SL , Francis PT , Procter AW , Palmer AM , Davison AN , Bowden DM . Gamma-Amminobutryic Acid Concentration in Brain Tissue at Two Stages of Alzheimer's disease . Brain 1988 ; 111 : 785 – 99 . 3401683 

  39. 39 Gamba P , Testa G , Sottero B , Gargiulo S , Poli G , Leonarduzzi G . The link between altered cholesterol metabolism and alzheimer's disease . Ann N Y Acad Sci 2012 ; 1259 : 54 – 64 . 10.1111/j.1749-6632.2012.06513.x 22758637 

  40. 40 Jones L , Holmans PA , Hamshere ML , Harold D , Moskvina V , Ivanov D , et al Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of alzheimer's disease . PLoS One 2010 ; 5 : e13950 10.1371/journal.pone.0013950 21085570 

  41. 41 Kloppenborg RP , van den Berg E , Kappelle LJ , Biessels GJ . Diabetes and other vascular risk factors for dementia: Which factor matters most? A systematic review . Eur J Pharmacol 2008 ; 585 : 97 – 108 . 10.1016/j.ejphar.2008.02.049 18395201 

  42. 42 Li L , Holscher C . Common pathological processes in alzheimer disease and type 2 diabetes: A review . Brain Res Rev 2007 ; 56 : 384 – 402 . 17920690 

  43. 43 Crane PK , Walker R , Hubbard RA , Li G , Nathan DM , Zheng H , et al Glucose levels and risk of dementia . N Engl J Med 2013 ; 369 : 540 – 8 . 10.1056/NEJMoa1215740 23924004 

  44. 44 McGeer PL , Schulzer M , McGeer EG . Arthritis and anti-inflammatory agents as possible protective factors for alzheimer's disease: A review of 17 epidemiologic studies . Neurology 1996 ; 47 : 425 – 32 . 8757015 

  45. 45 Leoutsakos JM , Muthen BO , Breitner JC , Lyketsos CG , ADAPT Research Team . Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical alzheimer disease: Findings from the randomized controlled alzheimer's disease anti-inflammatory prevention trial . Int J Geriatr Psychiatry 2012 ; 27 : 364 – 74 . 10.1002/gps.2723 21560159 

  46. 46 Xiang Z , Ho L , Yemul S , Zhao Z , Qing W , Pompl P , et al Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of alzheimer's disease neuropathology . Gene Expr 2002 ; 10 : 271 – 8 . 12450219 

  47. 47 Melnikova T , Savonenko A , Wang Q , Liang X , Hand T , Wu L , et al Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern . Neuroscience 2006 ; 141 : 1149 – 62 . 16753269 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로